Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03740334
Title Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications

acute lymphoblastic leukemia

Therapies

Dexamethasone + Ribociclib

Dexamethasone + Everolimus + Ribociclib

Age Groups: adult
Covered Countries USA


No variant requirements are available.